Dysport (abobotulinumtoxinA) is an FDA-approved botulinum toxin type A injectable that relaxes muscles to soften frown lines. Learn how it works, what it treats, results, safety, cost, and how it compares to Botox.
Dysport is a prescription injectable of abobotulinumtoxinA, a purified botulinum toxin type A. In small doses it temporarily blocks the nerve signals that make muscles contract, softening frown lines and other dynamic wrinkles. It is FDA-approved for glabellar lines, starts working in 2 to 3 days, and lasts about 3 to 4 months.
Dysport is one of the most widely used wrinkle-relaxing injectables in the United States and the closest direct alternative to Botox. It works by quieting the muscles that fold your skin into expression lines, not by filling or plumping. Understanding what Dysport is, how it differs from other neurotoxins, and where its FDA approvals end and off-label use begins helps you have a more informed, honest conversation with an injector.
*FDA status: Dysport (abobotulinumtoxinA) is FDA-approved for moderate to severe glabellar (frown) lines in adults and for two medical conditions. Many other facial areas are treated off-label. Unit counts are not interchangeable with Botox. This guide is educational and not a substitute for medical advice.*
Dysport is the brand name for abobotulinumtoxinA, a purified form of botulinum toxin type A produced by the bacterium Clostridium botulinum. It belongs to the same family of injectable neuromodulators as Botox, Xeomin, Jeuveau, and Daxxify, and it works by temporarily relaxing the specific muscles that create expression lines. In the United States its initial FDA approval dates to 2009. The medication is manufactured by Ipsen and marketed for aesthetic use in the US by Galderma Laboratories under license.
Dysport is supplied as a sterile, freeze-dried (lyophilized) powder in single-dose vials of 300 or 500 units, which a clinician reconstitutes with saline before injecting. Because it is a prescription drug, it can only be administered by or under the supervision of a licensed medical professional. It is important to understand that Dysport is a muscle relaxer, not a dermal filler: it does not add volume or plump the skin. Instead, it quiets the muscle activity underneath a wrinkle so the overlying skin creases less. That single distinction shapes everything else about the treatment, from which lines it can improve to how the results look and how long they last.
The awkward generic name is deliberate. When these products were approved, the FDA assigned each botulinum toxin its own distinct nonproprietary name, abobotulinumtoxinA for Dysport and onabotulinumtoxinA for Botox among them, specifically so that clinicians would not treat the products as interchangeable and misdose a patient by carrying a number across from one brand to another. The word unit deserves the same caution. A unit is a measure of biological potency defined by each manufacturer's own laboratory assay, not a universal measure of weight or volume, so a Dysport unit and a Botox unit are simply not the same quantity of anything. This is the root of most of the confusion patients encounter when comparing treatment plans or price quotes between clinics.
Every time you frown, squint, or raise your eyebrows, a nerve releases a chemical messenger called acetylcholine that signals the muscle to contract. Repeated contractions over years fold the skin above those muscles into lines that eventually stay visible even at rest. Dysport interrupts that process at the neuromuscular junction, the point where nerve meets muscle. The toxin binds to the nerve ending and blocks the release of acetylcholine, so the treated muscle receives no signal to contract and relaxes. With the muscle quieted, the skin above it smooths and dynamic wrinkles soften.
The effect is local and selective: it acts only on the muscles that receive the injection and does not alter skin sensation or affect nearby muscles that were not treated. The block is also temporary. Nerve endings gradually sprout new connections and regenerate over the following months, at which point normal muscle movement returns and the lines reappear unless the treatment is repeated. Compared with some other toxins, Dysport is formulated with smaller protein complexes, which many clinicians associate with a slightly faster onset and a modestly wider field of diffusion around each injection point. That wider spread can be an advantage across broad zones, but near delicate muscles it makes precise placement matter even more.
Dysport carries three FDA-approved indications in the United States. For cosmetic use, it is approved to temporarily improve the look of moderate to severe glabellar lines, the vertical frown lines between the eyebrows sometimes called the 11s, in adults under 65. Its other two approvals are medical rather than cosmetic: cervical dystonia, a painful neck-muscle disorder, in adults, and spasticity, or muscle stiffness, in patients 2 years of age and older. The toxin was used in neurology and ophthalmology for years before its cosmetic clearance, which is part of why it has a well-characterized safety profile.
Many popular aesthetic uses of Dysport fall outside these approvals and are considered off-label. Off-label does not mean unsafe or illegal: it means the FDA has not formally reviewed the product for that specific area, though clinicians may use it based on training and published evidence. A candid injector will tell you plainly which category your treatment falls into.
| Use | FDA status |
|---|---|
| Glabellar (frown) lines, adults under 65 | FDA-approved (cosmetic) |
| Cervical dystonia, adults | FDA-approved (medical) |
| Spasticity, age 2 and older | FDA-approved (medical) |
| Forehead lines, crow's feet | Off-label |
| Bunny lines, brow lift, masseter, neck bands | Off-label |
For the approved glabellar indication the evidence base is strong: randomized controlled trials supported approval and inform the standard 50-unit dose. Evidence for off-label facial areas is more variable, ranging from good for common sites like the forehead and crow's feet to limited for less studied uses. Ask where the evidence for your specific treatment stands.
A Dysport appointment is quick and requires no meaningful downtime for most people. It begins with a consultation in which the injector reviews your medical history, medications, and goals, and examines how your muscles move. Based on that assessment they map the injection points and decide on dosing. For frown lines, the FDA-approved regimen is a total of 50 units delivered in five small injections of 10 units each across the glabellar area.
The skin may be cleansed and, if you wish, numbed with a topical cream or ice, though many people find the injections tolerable without it. Using a fine needle, the clinician places the measured units into the targeted muscles. The injections themselves take only a few minutes and are often described as a quick pinch or sting. Afterward you can usually return to normal activities right away.
Common aftercare advice includes staying upright for several hours, avoiding rubbing or massaging the treated area, and skipping strenuous exercise, alcohol, and significant heat exposure for the rest of the day, all intended to keep the product where it was placed. You should not receive Dysport more often than every three months. Any bruising or minor swelling that occurs typically settles within a few days, and a follow-up at about two weeks lets your injector assess the result and add a small touch-up if one area needs it.
Dysport does not work instantly. The muscle-relaxing effect begins gradually, and most people notice softening of their lines within two to three days, which is often a touch sooner than the three to five days typical of Botox. The full effect develops over about one to two weeks as the toxin fully takes hold. At that point the treated lines look smoother, and in many cases dynamic wrinkles nearly disappear when you make the expression that normally creates them.
For most people the clinical effect lasts about three to four months, the same general range reported for Botox and consistent with the up-to-four-month duration described in the prescribing information. Duration is individual and depends on factors such as the dose used, the muscle treated, your metabolism, and how active or strong the muscle is. People with fast metabolisms or very expressive, strong muscles sometimes find results fade a little sooner.
As movement gradually returns, the lines reappear, which is the cue that it may be time to consider a maintenance treatment. There is no guarantee of a specific result or duration, and outcomes vary from person to person. Some people report that with consistent, repeated treatments over time the muscle becomes conditioned and results feel like they last slightly longer, though this is an observation rather than a promise.
For healthy adults treated by a trained, licensed injector, Dysport has a long safety record built over more than 15 years of clinical use. The most common side effects are mild and temporary: soreness, redness, swelling, or small bruises at the injection sites, and a headache in the hours after treatment. The effects that people worry about most, such as a drooping eyelid (ptosis), a heavy or uneven brow, or an asymmetric result, usually stem from where and how the product was placed or from it spreading to a nearby muscle, and they resolve as the product wears off over weeks. Choosing an experienced injector who understands facial anatomy is the single biggest factor in avoiding them.
Dysport carries an FDA boxed warning, the agency's strongest, about the distant spread of toxin effect. Rarely, the toxin can travel beyond the injection area and cause symptoms such as generalized muscle weakness, double or blurred vision, drooping eyelids, difficulty swallowing (dysphagia), changes in speech, loss of bladder control, or trouble breathing. Swallowing and breathing problems can be life threatening, and there have been rare reports of death; these are far more associated with higher therapeutic doses than with cosmetic dosing. Seek medical care immediately if any of these occur.
Dysport is not recommended during pregnancy or breastfeeding, for people with certain neuromuscular disorders, for anyone with a known allergy to any component including cow's milk protein, or for those with an active infection at the planned injection site. Be honest with your injector about your full medical history and every medication and supplement you take.
Dysport is one of several FDA-approved botulinum toxin type A products, alongside Botox (onabotulinumtoxinA), Xeomin (incobotulinumtoxinA), Jeuveau (prabotulinumtoxinA), and the longer-lasting Daxxify (daxibotulinumtoxinA). All share the same fundamental mechanism, and for most people the results are broadly comparable. Xeomin is a purified, additive-free formulation, while Daxxify is marketed for a longer duration; Dysport's distinguishing traits are its faster onset and slightly wider spread.
A crucial point is that units are not interchangeable between brands. Dysport is dosed on a different scale, and clinical studies generally use a conversion of roughly 2.5 to 3 Dysport units to 1 Botox unit, so a higher unit number on your Dysport chart does not mean you received more medication or a stronger dose.
| Attribute | Dysport | Botox |
|---|---|---|
| Active ingredient | abobotulinumtoxinA | onabotulinumtoxinA |
| Typical onset | 2 to 3 days | 3 to 5 days |
| Diffusion / spread | slightly wider | more localized |
| Unit conversion | about 2.5 to 3 units = 1 Botox unit | reference |
| Typical duration | 3 to 4 months | 3 to 4 months |
| Often favored for | broad areas like the forehead | precise, small areas |
The other products differ in ways that matter less than marketing suggests. Xeomin is manufactured without the accessory complexing proteins the others carry, which is sometimes argued to lower the chance of the body developing antibodies that blunt the response, though for most cosmetic patients that is a theoretical rather than a practical concern. Jeuveau is approved only for the cosmetic glabellar indication and has no medical approvals. Daxxify uses a peptide stabilizer in place of human serum albumin and reported longer duration in its trials, though real-world duration still varies and it is a newer product with a shorter track record than Dysport's fifteen-plus years.
It is worth being clear about the limits of the comparison evidence. Most head-to-head randomized trials study one area, the glabellar lines, over a few months, and they generally find the major toxins comparably effective at equivalent doses. Claims about which product performs better on the forehead, the crow's feet, or the masseter mostly rest on clinical experience rather than large comparative trials, and both the conversion ratio and the reputation for wider diffusion vary with how the product is diluted and injected. Treat confident brand rankings, including any on a clinic's own site, with appropriate skepticism.
Dysport's faster onset and slightly wider spread can make it efficient for larger zones such as the forehead, while Botox's more contained action is often preferred for small, precise targets like the frown lines or a lip flip. Neither is universally better, and many experienced injectors keep several toxins on hand and choose per area rather than committing to one brand. The right choice depends on your anatomy, the area being treated, and your injector's experience with each product.
Dysport is generally priced per unit, and because its units are smaller than Botox units, the per-unit price looks lower, often in the range of about 4 to 8 dollars per unit in many US markets. That figure can be misleading on its own, because it takes more Dysport units to equal a given Botox dose. The honest way to compare cost is by treated area or by total treatment, not by unit price alone. A single-area cosmetic treatment such as frown lines commonly runs a few hundred dollars, and treating multiple areas raises the total accordingly.
A common question is what 50 units costs, because 50 units is the FDA-approved dose for the frown-line area. Applying a typical per-unit range to that dose puts a single glabellar treatment in the low-to-mid hundreds of dollars in most US markets, but that is arithmetic, not a quote. Many clinics price the frown area as a flat package rather than per unit, some bundle a two-week touch-up and some charge separately for it, and your own muscle strength may mean your injector recommends more or fewer units than the label dose. Treat any number you find online, including this one, as a rough orientation only.
Prices vary widely and depend on your geographic region, the provider's expertise and setting, how many units your muscles require, and any current promotions or loyalty programs such as Galderma's Aspire rewards. Because Dysport for wrinkles is a cosmetic treatment, it is not covered by insurance; the medical indications, cervical dystonia and spasticity, may be covered when medically necessary.
Be cautious of prices that seem far below the local norm, since unusually cheap injectables can signal diluted product, an inexperienced injector, or a non-medical setting. The most reliable way to learn your actual cost is a consultation, where the injector can assess how many units you need and quote a total. We do not publish fixed prices because they genuinely vary by provider, region, and dose.
Dysport tends to suit adults who are bothered by dynamic wrinkles, the lines that appear with movement, particularly frown lines between the brows, and who want a temporary, adjustable treatment with little to no downtime. It is a strong candidate for broad areas like the forehead, where its diffusion can produce smooth, even results, though treating the forehead with Dysport is an off-label use. It is less useful for static lines that are visible at rest and etched into the skin, which are usually better addressed with dermal fillers or resurfacing, and it does not replace a good skincare or sun-protection routine.
You are generally not a good candidate if you are pregnant or breastfeeding, have a neuromuscular disorder such as myasthenia gravis or ALS, are allergic to any component including cow's milk protein, or have an active skin infection where you would be injected. Your injector should screen for these before treating you.
The most important decision you make is who holds the needle. Injection technique, dosing, and knowledge of facial anatomy determine both how natural your result looks and how low your risk of complications is. Look for a licensed, experienced medical provider, ask how many units they plan to use and why, and make sure they discuss FDA status and realistic expectations honestly. When you are ready, we can connect you with vetted, licensed injectors in your area who offer Dysport, so you can compare providers and book a consultation with confidence.
Yes. Both are botulinum toxin type A and work by the same mechanism, and studies find them comparably effective for softening frown lines. Dysport starts working a little faster and spreads slightly more. The best choice depends on the area treated and your injector's preference, not on one brand being stronger.
The wider spread that helps on broad areas demands precise placement near delicate muscles, or it can cause temporary brow or eyelid droop. Units are not interchangeable with Botox, which can confuse pricing. Results are temporary, lasting about 3 to 4 months, and cosmetic use is off-label for most areas beyond frown lines.
Dysport's per-unit price is usually lower, but it takes more Dysport units to match a Botox dose, so the per-area or per-treatment cost is often similar. Compare total treatment cost, not the per-unit number. Actual pricing varies by provider, region, and how many units you need.
No. At the low doses used for wrinkles, both have strong safety records. Because units are measured on different scales, a higher Dysport unit number does not mean a larger or more dangerous dose. Both carry the same FDA boxed warning about rare distant spread of toxin effect.
People who are pregnant or breastfeeding, have a neuromuscular disorder such as myasthenia gravis or ALS, are allergic to any ingredient including cow's milk protein, or have an active infection at the injection site should not receive Dysport. Discuss your full medical history with a licensed injector first.